OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Instagram Outage Disrupts Thousands of U.S. Users 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
FREMONT, Calif., March 01, 2016 -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS), a life sciences tools company focused on developing and commercializing technology platforms for genomics solutions, announced today that it will announce fourth quarter and full-year 2015 financial results after the market close, and host a conference call and webcast on Tuesday, March 8, 2016.
| Conference Call & Webcast | |||||
| Tuesday, March 8th at 5:00 PM Eastern Time: | |||||
| Domestic: | 877-407-3982 | ||||
| International: | 201-493-6780 | ||||
| Conference ID: | 13631278 | ||||
| Webcast: | http://public.viavid.com/index.php?id=118499 | ||||
| Replays, available through March 22: | |||||
| Toll-Free: | 877-870-5176 | ||||
| International: | 858-384-5517 | ||||
| Conference ID: | 13631278 | ||||
About WaferGen
WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The single cell analysis platform is a revolutionary system which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing (NGS). The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.
INVESTOR CONTACTS: LifeSci Advisors, LLC Brian Ritchie [email protected] WaferGen Bio-systems, Inc. Rollie Carlson [email protected]
